MORGAN STANLEY - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 19 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q3 2021$365,000
-89.6%
364,000
-89.5%
0.00%
Q2 2021$3,495,000
+39.5%
3,480,000
+40.7%
0.00%
Q1 2021$2,506,000
-27.2%
2,474,000
-22.0%
0.00%
-100.0%
Q4 2020$3,443,000
-40.5%
3,171,000
-42.9%
0.00%0.0%
Q3 2020$5,789,000
+45.0%
5,557,000
+53.2%
0.00%0.0%
Q2 2020$3,993,000
+18.4%
3,628,000
+10.2%
0.00%0.0%
Q1 2020$3,372,000
+110.8%
3,293,000
+135.7%
0.00%
Q4 2019$1,600,000
-64.4%
1,397,000
-64.6%
0.00%
-100.0%
Q3 2019$4,498,000
-61.1%
3,949,000
-59.5%
0.00%
-66.7%
Q2 2019$11,563,000
-22.6%
9,741,000
-11.9%
0.00%
-25.0%
Q1 2019$14,934,000
+5.3%
11,057,000
-16.4%
0.00%0.0%
Q4 2018$14,189,000
+30.6%
13,226,000
+28.4%
0.00%
+33.3%
Q3 2018$10,861,000
+40.9%
10,300,000
+30.9%
0.00%
+50.0%
Q2 2018$7,710,000
-1.0%
7,869,0000.0%0.00%0.0%
Q1 2018$7,788,000
-6.0%
7,869,000
+0.1%
0.00%0.0%
Q4 2017$8,285,000
+0.1%
7,859,000
+0.0%
0.00%0.0%
Q3 2017$8,279,000
+115.4%
7,857,000
+116.6%
0.00%
+100.0%
Q2 2017$3,844,000
-14.5%
3,627,000
-22.8%
0.00%0.0%
Q1 2017$4,496,000
-7.0%
4,696,000
-1.6%
0.00%0.0%
Q4 2016$4,834,000
+23.9%
4,774,000
+13.7%
0.00%0.0%
Q3 2016$3,900,000
-5.9%
4,200,000
-28.1%
0.00%0.0%
Q2 2016$4,145,000
-43.3%
5,839,000
-27.2%
0.00%
-66.7%
Q1 2016$7,314,000
-18.9%
8,026,000
+0.0%
0.00%0.0%
Q4 2015$9,018,0008,025,0000.00%
Other shareholders

There were no reported owners of ISIS PHARMACEUTICALS INC DEL in Q3 2021.

NameSharesValueWeighting ↓
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders